Determination of Neurodegeneration in Polycystic Ovary Syndrome with Retinal Segmentation Analysis

References

• Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223–36. doi:10.1056/NEJMra041536.
   PubMed Web of Science ®Google Scholar
• Acien P, Quereda F, Matallin P, Villarroya E, Lopez-Fernandez JA, Acien M, Mauri M, Alfayate R. Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil Steril. 1999;72(1):32–40. doi:10.1016/S0015-0282(99)00184-3.
   PubMed Web of Science ®Google Scholar
• Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745–49. doi:10.1210/jc.2003-032046.
   PubMed Web of Science ®Google Scholar
• Pasquali R, Gambineri A. Glucose intolerance states in women with the polycystic ovary syndrome. J Endocrinol Invest. 2013;36(8):648–53. doi:10.1007/BF03346757.
   PubMed Web of Science ®Google Scholar
• Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999;22(1):141–46. doi:10.2337/diacare.22.1.141.
   PubMed Web of Science ®Google Scholar
• Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347–63. doi:10.1093/humupd/dmq001.
   PubMed Web of Science ®Google Scholar
• Esmaeli B, Harvey JT, Hewlett B. Immunohistochemical evidence for estrogen receptors in meibomian glands. Ophthalmology. 2000;107(1):180–84. doi:10.1016/S0161-6420(99)00040-8.
   PubMed Web of Science ®Google Scholar
• Fuchsjager-Mayrl G, Nepp J, Schneeberger C, Sator M, Dietrich W, Wedrich A, Huber J, Tschugguel W. Identification of estrogen and progesterone receptor mrna expression in the conjunctiva of premenopausal women. Invest Ophthalmol Vis Sci. 2002;43:2841–44.
   PubMed Web of Science ®Google Scholar
• Vecsei PV, Kircher K, Kaminski S, Nagel G, Breitenecker G, Kohlberger PD. Immunohistochemical detection of estrogen and progesterone receptor in human cornea. Maturitas. 2000;36:169–72.
   PubMed Web of Science ®Google Scholar
• Ghasemi R, Dargahi L, Haeri A, Moosavi M, Mohamed Z, Ahmadiani A. Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders. Mol Neurobiol. 2013;47:1045–65.
   PubMed Web of Science ®Google Scholar
• Acmaz G, Atas M, Gulhan A, Acmaz B, Atas F, Aksoy H. Evaluation of the macula, retinal nerve fiber layer, and choroid thickness in women with polycystic ovary syndrome using spectral-domain optical coherence tomography. Reprod Sci. 2014;21(8):1044–49. doi:10.1177/1933719114522523.
   PubMed Web of Science ®Google Scholar
• Demir M, Guven D, Koc A, Ozdemir S, Can E. Retinal nerve fiber layer thickness in women with polycystic ovary syndrome. J Ophthalmol. 2013;2013:752186. doi:10.1155/2013/752186.
   PubMed Web of Science ®Google Scholar
• de Souza-junior JE, Garcia CA, Soares EM, Maranhao TM, Lemos TM, Azevedo GD. Polycystic ovary syndrome: aggressive or protective factor for the retina? Evaluation of macular thickness and retinal nerve fiber layers using high-definition optical coherence tomography. J Ophthalmol. 2015;2015:193078.
   PubMed Web of Science ®Google Scholar
• Delitala AP, Capobianco G, Delitala G, Cherchi PL, Dessole S. Polycystic ovary syndrome, adipose tissue and metabolic syndrome. Arch Gynecol Obstet. 2017;296(3):405–19. doi:10.1007/s00404-017-4429-2.
   PubMed Web of Science ®Google Scholar
• Niafar M, Pourafkari L, Porhomayon J, Nader N. A systematic review of glp-1 agonists on the metabolic syndrome in women with polycystic ovaries. Arch Gynecol Obstet. 2016;293(3):509–15. doi:10.1007/s00404-015-3976-7.
   PubMed Web of Science ®Google Scholar
• Karaca C, Karaca Z. Beyond hyperglycemia, evidence for retinal neurodegeneration in metabolic syndrome. Invest Ophthalmol Vis Sci. 2018;59(3):1360–67. doi:10.1167/iovs.17-23376.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. doi:10.1016/j.fertnstert.2003.10.004.
   Web of Science ®Google Scholar
• Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–19. doi:10.1007/BF00280883.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2017;40(Suppl1):S11–s24. doi:10.2337/dc17-S005.
   PubMedGoogle Scholar
• Group ETDRSR. Grading diabetic retinopathy from stereoscopic color fundus photographs–an extension of the modified airlie house classification. Etdrs report number 10. Ophthalmology. 1991;98(5Suppl):786–806. doi:10.1016/S0161-6420(13)38012-9.
   PubMedGoogle Scholar
• Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004;89(2):453–62. doi:10.1210/jc.2003-031122.
   PubMed Web of Science ®Google Scholar
• Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril. 2005;83(6):1717–23. doi:10.1016/j.fertnstert.2005.01.096.
   PubMed Web of Science ®Google Scholar
• Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (ae-pcos) society. J Clin Endocrinol Metab. 2010;95:2038–49.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;88(4):787–835, ix. doi:10.1016/j.mcna.2004.04.013.
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774–800.
   PubMed Web of Science ®Google Scholar
• Vujosevic S, Midena E. Retinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and muller cells alterations. J Diabetes Res. 2013;2013:905058. doi:10.1155/2013/905058.
   PubMed Web of Science ®Google Scholar
• Pasquali R. Metabolic syndrome in polycystic ovary syndrome. In Metabolic Syndrome Consequent to Endocrine Disorders (pp. 114–130), Karger Publishers, 2018. doi: 10.1159/000485995.
   Google Scholar
• Peng XY, Wang FH, Liang YB, Wang JJ, Sun LP, Peng Y, Friedman DS, Liew G, Wang NL, Wong TY. Retinopathy in persons without diabetes: the handan eye study. Ophthalmology. 2010;117(3):531–537. e532. doi:10.1016/j.ophtha.2009.07.045.
   PubMed Web of Science ®Google Scholar
• Liu L, Yue S, Wu J, Zhang J, Lian J, Teng W, Huang D, Chen L. Prevalence and risk factors of retinopathy in patients with or without metabolic syndrome: A population-based study in shenyang. BMJ Open. 2015;5(12):e008855. doi:10.1136/bmjopen-2015-008855.
   PubMed Web of Science ®Google Scholar
• Keenan JD, Fan AZ, Klein R. Retinopathy in nondiabetic persons with the metabolic syndrome: findings from the third national health and nutrition examination survey. Am J Ophthalmol. 2009;147(5):934–944. e932. doi:10.1016/j.ajo.2008.12.009.
   PubMed Web of Science ®Google Scholar
• Wong TY, Duncan BB, Golden SH, Klein R, Couper DJ, Klein BE, Hubbard LD, Sharrett AR, Schmidt MI. Associations between the metabolic syndrome and retinal microvascular signs: the atherosclerosis risk in communities study. Invest Ophthalmol Vis Sci. 2004;45(9):2949–54. doi:10.1167/iovs.04-0069.
   PubMed Web of Science ®Google Scholar
• Tavares Ferreira J, Alves M, Dias-Santos A, Costa L, Santos BO, Cunha JP, Papoila AL, Abegao Pinto L. Retinal neurodegeneration in diabetic patients without diabetic retinopathy. Invest Ophthalmol Vis Sci. 2016;57(14):6455–60. doi:10.1167/iovs.16-20215.
   PubMed Web of Science ®Google Scholar
• Bronson-Castain KW, Bearse MA Jr., Neuville J, Jonasdottir S, King-Hooper B, Barez S, Schneck ME, Adams AJ. Early neural and vascular changes in the adolescent type 1 and type 2 diabetic retina. Retina. 2012;32(1):92–102. doi:10.1097/IAE.0b013e318219deac.
   PubMed Web of Science ®Google Scholar
• van Dijk HW, Kok PH, Garvin M, Sonka M, Devries JH, Michels RP, van Velthoven ME, Schlingemann RO, Verbraak FD, Abramoff MD. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009;50:3404–09.
   PubMed Web of Science ®Google Scholar
• Ozkaya A, Alkin Z, Karakucuk Y, Karatas G, Fazil K, Gurkan Erdogan M, Perente I, Taskapili M. Thickness of the retinal photoreceptor outer segment layer in healthy volunteers and in patients with diabetes mellitus without retinopathy, diabetic retinopathy, or diabetic macular edema. Saudi J Ophthalmol. 2017;31(2):69–75. doi:10.1016/j.sjopt.2016.12.006.
   PubMed Web of Science ®Google Scholar
• Verma A, Rani PK, Raman R, Pal SS, Laxmi G, Gupta M, Sahu C, Vaitheeswaran K, Sharma T. Is neuronal dysfunction an early sign of diabetic retinopathy? Microperimetry and spectral domain optical coherence tomography (sd-oct) study in individuals with diabetes, but no diabetic retinopathy. Eye. 2009;23(9):1824–30. doi:10.1038/eye.2009.184.
   PubMed Web of Science ®Google Scholar
• Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol. 2004;3(3):169–78. doi:10.1016/S1474-4422(04)00681-7.
   PubMed Web of Science ®Google Scholar
• Schubert M, Gautam D, Surjo D, Ueki K, Baudler S, Schubert D, Kondo T, Alber J, Galldiks N, Küstermann E. Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci. 2004;101(9):3100–05. doi:10.1073/pnas.0308724101.
   PubMed Web of Science ®Google Scholar
• Reiter CE, Wu X, Sandirasegarane L, Nakamura M, Gilbert KA, Singh RS, Fort PE, Antonetti DA, Gardner TW. Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin. Diabetes. 2006;55(4):1148–56. doi:10.2337/diabetes.55.04.06.db05-0744.
   PubMed Web of Science ®Google Scholar
• Rajala A, Dighe R, Agbaga M-P, Anderson RE, Rajala RV. Insulin receptor signaling in cones. J Biol Chem. 2013;288:19503–15.
   PubMedGoogle Scholar
• Natalini PM, Mateos MV, Ilincheta de Boschero MG, Giusto NM. Insulin-related signaling pathways elicited by light in photoreceptor nuclei from bovine retina. Exp Eye Res. 2016;145:36–47. doi:10.1016/j.exer.2015.10.020.
   PubMed Web of Science ®Google Scholar
• Spritzer PM, Lecke SB, Satler F, Morsch DM. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015;149(5):R219–227. doi:10.1530/REP-14-0435.
   PubMed Web of Science ®Google Scholar
• Gonzalez F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77(4):300–05. doi:10.1016/j.steroids.2011.12.003.
   PubMed Web of Science ®Google Scholar